No one fighting cancer should have to deal with fake medicines too.

The Every Dose Matters campaign safeguards lives and strengthens trust in cancer care worldwide by equipping patients, providers, and caregivers with the resources and skills to prevent, detect, and combat fake cancer medicines.

Vital chemotherapy and cancer medicines routinely fail quality tests worldwide. Substandard and falsified (aka fake) cancer medicines are one of the greatest threats to cancer care globally, undermining patient trust in legitimate treatments, the integrity of healthcare systems, and hard-won progress against cancer.

The threat is real. Yet, those affected most know the least.

We believe knowledge saves lives and ensures no cancer patient is deprived of their right to legitimate and safe medicines. This campaign empowers physicians, pharmacists, and nurses, as well as patients, through targeted education, practical tools, and active engagement to recognize risks, report suspicious products, and strengthen vigilance across the cancer supply chain.

Every Dose Matters is an initiative of the Behavioral and Educational Strategies for Falsified Medicine Exposure (BESAFE) at the Johns Hopkins Bloomberg School of Public Health

What are fake cancer medicines?

Fake cancer medicines — also called substandard or falsified medicines — are drugs that are poor-quality, incorrectly made, or deliberately misrepresented. They may contain the wrong ingredients, too little of the real drug, or toxic substances. Fake cancer medicines include pill and intravenous therapies.

Fake treatments put patients’ lives at risk by delaying effective care and causing dangerous side effects.

As cancer medicine shortages and high costs push more people to buy from unregulated online pharmacies, fake cancer medicines aren’t rare, and they’re not just a problem for low- and middle-income countries (LMICs).

Today substandard and falsified cancer medicines are found in 100 countries, including in high-income countries.

.

Authentic (top) versus fake (bottom) Avastin that was distributed in the United States in 2012. Mistakes in packaging, such as lack of branding and foreign language instructions, are visible in the fake Avastin.

10-30% of all medicines are fake in LMICs.

Estimates may be even higher for substandard and falsified cancer medicines. In Africa, 1 in 6 cancer medicines were found to be substandard in one study.

Fake cancer medicines have deadly impacts.

At best, they delay access to real treatments and let cancer progress. At worst, adverse events, organ failure or death. While mortality estimates for cancer meds are unknown, substandard and falsified meds across all categories kill 500,000 in Africa each year.

Fake cancer medicines are stifling global development.

Are you at risk?

With the rise of online pharmacies, everyone — from the United States to Nigeria — is at risk. However, low- and middle-income countries bear the brunt of the problem. Learn how fake cancer medicines reach patients (insert link). You may be at higher risk of encountering a substandard or falsified cancer medicine if:


Patients, physicians, nurses and pharmacists can all take steps to prevent and protect themselves and those in their care from exposure to fake cancer medicines. It’s as easy as PIE(S):
 

P. Precaution before purchasing.

I. Inspect the packaging.

E. Examine the medicine’s appearance.

S. Speak up and report to relevant authorities when suspicious.

Read how fake cancer medicines have changed real lives

For patients. For providers. For real cancer care. #NoFakesAllowed